Bruce Walcheck

ORCID: 0000-0003-1933-3887

Also affiliated with University of Minnesota Medical Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Dual antigen–targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia”.

Dual antigen–targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia

Blood(2022)10.1182/blood.2021015184

N/A

0.665DataRank · unranked

83 citations

Jodie P. Goodridge, Ryan Bjordahl, Sajid Mahmood, Zachary Davis, Svetlana Gaidarova +15 more

Ectodomain shedding by ADAM17 (a disintegrin and metalloproteinase 17) in canine neutrophils

Veterinary Immunology and Immunopathology(2020)10.1016/j.vetimm.2020.110162

N/A

0.292DataRank · unranked

6 citations

Camille A. McAloney, Joshua S. Montel, Jaime F. Modiano, Bruce Walcheck, Kristin M. Snyder

Ablation of SYK kinase from primary human Natural Killer cells via CRISPR/Cas9 enhances cytotoxicity and cytokine production

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.29.493889

N/A

0.104DataRank · unranked

1 citations

Jenna K. Dick, Jules Sangala, Emily J. Pomeroy, Kristin M. Snyder, Juliette M. Moushon +10 more

Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor

Cancers(2021)10.3390/cancers13215446

N/A

0DataRank · unranked

22 citations

Abdolkarim Sheikhi, Roeland Lameris, Lisa A. King, Amanda van Vliet, Bruce Walcheck +6 more

Simultaneous Engagement of Tumor and Stroma Targeting Antibodies by Engineered NK-92 Cells Expressing CD64 Controls Prostate Cancer Growth

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0178

N/A

0DataRank · unranked

21 citations

Kristin M. Snyder, Jianming Wu, Robert Hullsiek, James D. Dahlvang, Geoffrey T. Hart +3 more

197 Novel FcyR recombinant fusion facilitates antibody arming of engineered iPSC-derived NK cells to enhance targeting and killing of ovarian cancer cells

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.197

N/A

0DataRank · unranked

0 citations

Kate Dixon, Melissa Khaw, Zachary Davis, Paul Rogers, Martin Hosking +5 more

Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma

Nature Communications(2022)10.1038/s41467-022-35127-2

N/A

0DataRank · unranked

76 citations

Ryan Bjordahl, Jodie P. Goodridge, Sajid Mahmood, Svetlana Gaidarova, Ramzey Abujarour +18 more

Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells

Frontiers in Immunology(2022)10.3389/fimmu.2022.841859

N/A

0DataRank · unranked

24 citations

Yunfang Li, Kristin M. Snyder, Sam C. Wang, Da Di, Antonella Borgatti +8 more

Detection of Antibody-Dependent Cell-Mediated Cytotoxicity—Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization

Antibodies(2023)10.3390/antib12030044

N/A

0DataRank · unranked

2 citations

Bruce Walcheck, Julie Smith‐Gagen, Vincent C. Lombardi, Dorothy Hudig, Judith Cruz Amaya

Detection of ADCC-Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization

Preprints.org(2023)10.20944/preprints202305.1841.v1

N/A

0DataRank · unranked

1 citations

Bruce Walcheck, Julie Smith‐Gagen, Vincent C. Lombardi, Dorothy Hudig, Judith Cruz Amaya

Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-008959

N/A

0DataRank · unranked

11 citations

Rob H. Hullsiek, Kate Dixon, Sam C. Wang, Anders Lindstedt, Ryan R. Friess +8 more

Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.05.09.593347

N/A

0DataRank · unranked

1 citations

Rob H. Hullsiek, Kate Dixon, Sam C. Wang, Anders Lindstedt, Ryan R. Friess +8 more

Bypassing NK cell limitations in the tumor microenvironment through novel Poly-Antigen Cytokine Complexes 2287

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.222

N/A

0DataRank · unranked

0 citations

Melissa Khaw, Marieke van Breukelen, Anders W. Matson, Yvette Soignier, Laura E. Bendzick +10 more

Simultaneous ADAM17 inhibition and CD16A stimulation augments memory-like NK cell activation and proliferation 3748

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1513

N/A

0DataRank · unranked

0 citations

Kathleen J. Dixon, Anders W. Matson, Sam C. Wang, Bruce Walcheck, Robert Hullsiek

Blocking ADAM17 Function with a Monoclonal Antibody Improves Sepsis Survival in a Murine Model of Polymicrobial Sepsis

International Journal of Molecular Sciences(2020)10.3390/ijms21186688

N/A

0DataRank · unranked

17 citations

Jing Ma, Daniel C. Mendez, Robert Hullsiek, Nabendu Pore, Bruce Walcheck +1 more

Targeted ADAM17 blocker directed to CD16 (TAB16) augments NK cell proliferation and cytotoxicity 3752

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1517

N/A

0DataRank · unranked

0 citations

Robert Hullsiek, Ryan R. Friess, Anders W. Matson, Sam C. Wang, Jianming Wu +5 more

Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy

Cell stem cell(2021)10.1016/j.stem.2021.08.013

N/A

0DataRank · unranked

156 citations

Hansol Kim, Ryan Bjordahl, Zachary Davis, Svetlana Gaidarova, John Goulding +26 more

Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation

Frontiers in Immunology(2021)10.3389/fimmu.2021.711621

N/A

0DataRank · unranked

25 citations

Kate Dixon, Nabendu Pore, Martin Felices, Jeffrey S. Miller, Bruce Walcheck +1 more